1.
Grande Vides M, Erazo K. Comparison between dolutegravir or efavirenz-based therapy in population with Human Inmunodeficiency Virus. Rev. Cient. Esc. Univ. Cienc. Salud [Internet]. 2023 Dec. 7 [cited 2024 Oct. 19];9(2):29-38. Available from: https://camjol.info/index.php/RCEUCS/article/view/17261